spacer
 HOME PAGE
Today’s columns, news and more
 BASICS
Build your financial know-how
 INVESTING
Tips and tools for your portfolio
 YOUR FINANCES
Latest rates and money-saving tips
 PLANNING
Put your financial goals into action
 SPENDING
Research home, car and other purchases
 TOOLS
Calculators for financial decisions
 COLUMNS
Advice and commentary from Kiplinger's experts
 COMMUNITY
Ask a question or answer one
 EMAIL UPDATES
Sign Up!
 PUBLICATIONS
Subscribe, renew, buy books and software
 CONTACT US
Customer service, feedback, letters to the editor
 ABOUT US
Company privacy and advertising info
 

BOOST YOUR 401(K)
New online course
from Kiplinger helps
you make the most
of your savings.
See how...

Try a Free IssueKiplinger Store:
Give a Gift Subscription
for Just $10

Investing:  MARKET SNAPSHOT   STOCKS   FUNDS   BONDS  PORTFOLIO TRACKER
RESEARCH   EARNINGS CENTER    STOCKS TO WATCH    BUYING & SELLING STRATEGIES   STOCK FINDER  
GETTING STARTED
bullet Build a Strong Stock Portfolio
bullet Earnings: The Bottom Line
bullet Ten Clues to Strong Stocks
bullet Four Questions to Ask Before You Buy
bullet A Kid-Friendly Introduction to Stocks
bullet MORE...
STOCK TOOLS
bullet Kiplinger's Stock Finder
bullet Test your risk tolerance
bullet What is the current yield from dividends?
bullet Which are better: income or growth stocks?
bullet Pick the Best 'Bankerage' Company
Recent Columns
Hilton: Rooms to Grow - Feb. 4, 2005
PepsiCo: Blue-Chip Carbs - Feb. 3, 2005
Google: On the Fast Track - Feb. 2, 2005
Sprint: What's Next(el)? - Feb. 1, 2005
Bank of America: Earning Interest - Jan. 31, 2005
Home Depot: Building on Success - Jan. 28, 2005
MORE ...
  Email this  Print this
License or reprint this article

NBTY: Low-Profile Performer

NBTY (NBTY) is the number one wholesaler and one of the largest vitamin and food supplement retailers in the U.S. and Europe.

The company markets its products under the Nature's Bounty, Puritan's Pride and Vitamin World brand names and sells them through storefronts and catalogs. Sales have been rising steadily as the popularity of vitamins and natural therapies widens.

The February 10 issue of Dow Theory Forecasts spotlighted NBTY for its so-called "light-blue chip" qualities. In other words, it's a top-notch company that has market dominance and a track record of growth. Plus, it's trading at a value.

NBTY's December same-store sales rose 12% from a year ago and operating profit margins increased to 11.4% from 10.8%, despite stiff pricing pressure. The company also delivers a solid 14% return on assets and has more than $46 million in cash on the books.

Analysts at Dow Theory say NBTY's penchant for acquiring bankrupt competitors for pennies on the dollar will pay off in the long run. They see NBTY as a buy candidate for its ability to perform over the next 12 months. The stock trades at less than 14 times the 2003 consensus earnings estimate of $1.34 per share. Analysts expect 20% earnings growth, on average, over the next three to five years.

-- Elizabeth Frengel

NBTY

Click for larger chart
Today's quote
Use Stock Finder to make your own stock picks

Company Snapshot
Full Report
Earnings Snapshot
SEC Filings

ADVERTISEMENT

  SPONSORED LINKS

Terms & Conditions | Customer Service | Subscribe by phone:  800-544-0155
All contents © 2005 The Kiplinger Washington Editors, Inc.